{"id":"https://openalex.org/W4387003842","doi":"https://doi.org/10.1016/s2152-2650(23)01896-7","title":"P-278 Estimating the size of patients with relapsed/ refractory multiple myeloma treated with 1-3 and 4 or more prior lines of therapy in the United States","display_name":"P-278 Estimating the size of patients with relapsed/ refractory multiple myeloma treated with 1-3 and 4 or more prior lines of therapy in the United States","publication_year":2023,"publication_date":"2023-09-01","ids":{"openalex":"https://openalex.org/W4387003842","doi":"https://doi.org/10.1016/s2152-2650(23)01896-7"},"language":"en","primary_location":{"id":"doi:10.1016/s2152-2650(23)01896-7","doi":"https://doi.org/10.1016/s2152-2650(23)01896-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(23)01896-7","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047819225","display_name":"Doris K. Hansen","orcid":"https://orcid.org/0000-0002-9813-3578","observed_orcids":["https://orcid.org/0000-0002-9813-3578"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Doris Hansen","raw_affiliation_strings":["Moffiitt Cancer Center;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffiitt Cancer Center;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047559786","display_name":"Akshay A. Kharat","orcid":"https://orcid.org/0000-0002-1056-9466","observed_orcids":["https://orcid.org/0000-0002-1056-9466"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Akshay Kharat","raw_affiliation_strings":["Janssen Pharmaceuticals;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Pharmaceuticals;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048970467","display_name":"Ravi C. Potluri","orcid":"https://orcid.org/0000-0002-0509-2659","observed_orcids":["https://orcid.org/0000-0002-0509-2659"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ravi Potluri","raw_affiliation_strings":["Putnam Associates;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Putnam Associates;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112990210","display_name":"Sanjog Patidar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sanjog Patidar","raw_affiliation_strings":["Putnam Associates;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Putnam Associates;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109506199","display_name":"Stephen Huo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen Huo","raw_affiliation_strings":["Janssen Pharmaceuticals;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Pharmaceuticals;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001877903","display_name":"Jack Khouri","orcid":"https://orcid.org/0000-0002-2473-6528","observed_orcids":["https://orcid.org/0000-0002-2473-6528"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jack Khouri","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic","institution_ids":["https://openalex.org/I1316902750"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3670,"currency":"USD","value_usd":3670},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"23","issue":null,"first_page":"S189","last_page":"S189"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/relapsed-refractory-multiple-myeloma","display_name":"relapsed/refractory multiple myeloma","score":0.9819999933242798},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.890999972820282},{"id":"https://openalex.org/keywords/daratumumab","display_name":"daratumumab","score":0.7179999947547913},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.8080000281333923},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9570000171661377},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7319999933242798},{"id":"https://openalex.org/keywords/prior-lines-of-therapy","display_name":"prior lines of therapy","score":0.578000009059906}],"concepts":[{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.723708987236023},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6896443367004395},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5237962007522583},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4419119656085968},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39872100949287415},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.07745301723480225},{"id":"https://openalex.org/C191897082","wikidata":"https://www.wikidata.org/wiki/Q11467","display_name":"Metallurgy","level":1,"score":0.04994800686836243}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s2152-2650(23)01896-7","doi":"https://doi.org/10.1016/s2152-2650(23)01896-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(23)01896-7","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4324018675","https://openalex.org/W2890956331","https://openalex.org/W4323341927","https://openalex.org/W3114816661","https://openalex.org/W2979520565","https://openalex.org/W4389228859","https://openalex.org/W2999458003","https://openalex.org/W4389231707","https://openalex.org/W3168449182","https://openalex.org/W3192759045"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-09-26T00:00:00"}